Abstract
The regulation of growth hormone (GH) secretion involves a complex neuro-endocrine control system that includes the participation of neurotransmitters and feedback by hormonal and metabolic substrates. The final common integrative pathway for these signals consists of two neuropeptides, which are hypophysiotropic hormones: GH-releasing hormone (GRH), a 40–44-residue peptide which exerts stimulatory effects on GH secretion, and somatostatin (SRIF), a tetradecapeptide which exhibits an inhibitory influence. Although other hypothalamic neuropeptides and monoamines can be demonstrated to exert effects on GH secretion when injected or added to somatotrophs in vitro, there is as yet no convincing evidence for their direct effects on the pituitary under physiologic conditions. They may, however, exert important indirect effects on the regulation of GH secretion by modifying the secretion of GRH and SRIF. Similarly, GRH and SRIF participate in the regulation of GH secretion by neurotransmitter effects within the central nervous system (CNS) on one another or by autocrine effects on their own secretion via ultrashort loot) feedback mechanisms.
The studies in the authors’ laboratory were supported by USPHS grants DK 30667 and RR00068.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abe H, Molitch ME, van Wyk J, Underwood LE (1983) Human growth hormone and somatomedin-C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 113:1319–1324
Abrams RL, Grumbach MM, Kaplan SL (1971) The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man. J Clin Invest 50:940–950
Berelowitz M, Firestone SL, Frohman LA (1981a) Effects of growth hormone excess and deficiency on hypothalamus somatostatin content and release and on tissue somatostatin distribution. Endocrinology 109:714–719
Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL (1981b) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212:1279–1281
Bilezikjian LM, Vale WW (1984) Chronic exposure of cultured rat anterior pituitary cells to GRF causes partial loss of responsivess to GRF. Endocrinology 115:2032–2034
Borges JLC, Blizzard RM, Gelato MC, Furlanetto R, Rogol AD, Evans WS, Vance ML, Kaiser DL, MacLeod RM, Merriam GR, Loriaux DL, Spiess J, Rivier J, Vale W, Thorner MO (1981) Effects of human pancreatic tumour growth hormone-releasing factor on growth hormone and somatomedin-C levels in patiens with idiopathic growth hormone deficiency. Lancet ii:119–123
Cheng TC, Beamer WG, Phillips JA III, Bartke A, Mallone RL, Dowling AC (1983) Etiology of growth hormone deficiency in little, Ames and Snell dwarf mice. Endocrinology 113:1669–1678
Chomczynski P, Downs TR, Frohman LA (1987) Feedback regulation of growth hormone (GH)-releasing hormone (GRH) gene expression by growth hormone in rat hypothalamus. 69th Annual Meeting Endocrine Society (abstract 617)
Ferland L, Labrie F, Jobin M, Arimura A, Schally AV (1976) Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun 68: 149–156
Frohman LA, Downs TR (1987) Ectopic GRH syndrome. In: Robbins R, Melmed S (eds) Acromegaly: A Century of Scientific and Clinical Progress. Plenum, New York, pp 115–126
Frohman LA, Jansson J-O (1986) Growth hormone-relasing hormone. Endocr Rev 7:223–253
Frohman MA, Frohman LA, Goldman MB, Goldman JN (1979) Use of protein-A-containing staphylococcus aureus as an immuno-adsorbant in radioimmunoassays to separate antibody-bound from free antigen. J Lab Clin Med 93: 614–621
Frohman LA, Downs TR, Williams TC, Heimer EP, Pan Y-CE, Felix AM (1986) Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitroand in vivoto a biologically inactive, N-terminally cleaved product. J Clin Invest 78:906–913
Frohman LA, Downs TR, Heimer EP, Felix AM (1987) Characterization of the primary human growth hormone-releasing hormone-degrading enzyme in plasma as dipeptidyl-aminopeptidase, type IV. Clin Res 35: 884A
Gelato MC, Ross JL, Malozowski S, Pescovitz OH, Skerda M, Cassorla F, Loriaux DL, Merriam GR (1985) Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short-term linear growth in children with GH deficiency. J. Clin Endocrinol Metab 61: 444–450
Ikuyama S, Nawata H, Kato K-I, Ibayashi H, Nakagaki H (1986) Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients. J Clin Endocrinol Metab 62: 729–733
Jansson J-O, Downs TR, Beamer WG, Frohman LA (1986a) Receptor-associated resistance to growth hormone-releasing hormone in growth hormone-deficient dwarf “little” mice. Science 232:511–512
Jansson J-O, Downs TR, Beamer WG, Frohman LA (1986b) The dwarf “little” (lit/lit) mouse is resistant to growth hormone-releasing peptide (GHRP-6) as well as to growth hormone-releasing hormone. 68th Annual Meeting Endocrine Society (abstract 397)
Katakami H, Berelowitz M, Marbach M, Frohman LA (1985) Modulation of somatostatin binding to rat pituitary membranes by exogenously administered growth hormone. Endocrinology 111:557–560
Katakami H, Arimura A, Frohman LA (1986) Growth hormone-releasing hormone stimulates hypothalamic somatostatin release: a inhibitory feedback effect on growth hormone secretion. Endocrinology 118:1872–1877
Katakami H, Downs TR, Frohman LA (1987) Effect of hypophysectomy on hypothalamic growth hormone-releasing hormone content and release in the rat. Endocrinology 120: 1079–1082
Kelijman M, Williams TC, Downs TR, Frohman LA (1987) Comparison of the sensitivity of growth hormone secretion to somatostatin in vivoand in vitroin acromegaly. Clin Res 35: 585A
Mitchell JA, Hutchins M, Schindler WJ, Critchlow V (1973) Increases in plasma growth hormone and naso-anal length in rats following isolation of the medial basal hypothalamus. Neuroendocrinology 12:161–173
Plotsky PM, Vale W (1985) Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophyseal-portal circulation of the rat. Science 230:461–463
Quabbe H-J, Schilling E, Helge H (1966) Pattern of growth hormone secretion during a 24-hour fast in normal adults. J Clin Endocrinol Metab 26: 1173–1177
Reubi JC, Heitz PU, Landolt AM (1987) Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J Clin Endocrinol Metab 65: 65–73
Rosenthal SM, Hülse JA, Kaplan SL, Grumbach MM (1986) Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men. Clin Invest 77: 176–180
Schriock EA, Lustig RH, Rosenthal SM, Kaplan SL, Grumbach MM (1984) Effect of growth hormone (GH)-releasing hormone (GRF) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency. J Clin Endocrinol Metab 58: 1043–1049
Snyder PJ, Rudenstein RS, Gardner DF, Rothman JG (1979) Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism. J Clin Endocrinol Metab 48: 864–868
Tannenbaum GS, Ling N (1984) The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115:1952–1957
Vance ML, Borges JLC, Kaiser DL, Evans WS, Furlanetto R, Thominet JL, Frohman LA, Rogol AD, MacLeod RM, Bloom S, Rivier J, Vale W, Thorner MO (1984) Human pancreatic tumor growth hormone-releasing factor (hpGRF-40): dose-response relationships in normal man. J Clin Endocrinol Metab 58: 838–844
Wehrenberg WB, Brazeau P, Luben R, Böhlen P, Guillemin R (1982) Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone-releasing factor (GRF). Endocrinology 111:2147–2148
Wehrenberg WB, Brazeau P, Ling N, Textor G, Guillemin R (1984) Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. Endocrinology 114:1613–1616
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Frohman, L.A., Chomczynski, P., Downs, T.R., Katakami, H., Jansson, JO. (1989). Growth hormone releasing hormone and somatostatin in the physiology and pathophysiology of growth hormone secretion. In: MÜller, E.E., Cocchi, D., Locatelli, V. (eds) Advances in Growth Hormone and Growth Factor Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11054-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-11054-6_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-11056-0
Online ISBN: 978-3-662-11054-6
eBook Packages: Springer Book Archive